Amedeo Smart

Free Medical Literature Service


 

Amedeo

Inflammatory Bowel Diseases

  Free Subscription

25.03.2024

1 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 BMC Gastroenterol
1 Clin Exp Immunol
4 Clin Gastroenterol Hepatol
1 Clin Res Hepatol Gastroenterol
2 Dig Dis Sci
1 Gastroenterology
3 Inflamm Bowel Dis
4 J Crohns Colitis
1 J Gastroenterol
1 J Immunol
2 PLoS One
2 Scand J Gastroenterol



    Aliment Pharmacol Ther

  1. AKIYAMA S, Yokoyama K, Yagi S, Shinzaki S, et al
    Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.
    Aliment Pharmacol Ther. 2024 Mar 17. doi: 10.1111/apt.17961.
    >> Share


    Am J Gastroenterol

  2. ALLEGRETTI JR, Axelrad J, Dalal RS, Kelly CR, et al
    Outcomes after Fecal Microbiota Transplantation in combination with Bezlotoxumab for Inflammatory Bowel Disease and Recurrent C . difficile Infection.
    Am J Gastroenterol. 2024 Mar 19. doi: 10.14309/ajg.0000000000002770.
    >> Share


    BMC Gastroenterol

  3. HU N, Liu J, Gao X, Tang H, et al
    Correction: The association between hemoglobin level and sarcopenia in Chinese patients with Crohn's disease.
    BMC Gastroenterol. 2024;24:115.
    >> Share


    Clin Exp Immunol

  4. DUARTE-SILVA M, Parra RS, Feitosa MR, Nardini V, et al
    Leukocyte Dysfunction and reduced CTLA-4 Expression are Associated with Perianal Crohn's Disease.
    Clin Exp Immunol. 2024 Mar 22:uxae027. doi: 10.1093.
    >> Share


    Clin Gastroenterol Hepatol

  5. COLOMBEL JF, Hisamatsu T, Atreya R, Bresso F, et al
    Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
    Clin Gastroenterol Hepatol. 2024 Mar 14:S1542-3565(24)00254.
    >> Share

  6. PEYRIN-BIROULET L, Panaccione R, Louis E, Atreya R, et al
    Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
    Clin Gastroenterol Hepatol. 2024 Mar 14:S1542-3565(24)00253.
    >> Share

  7. PRENTICE R, Flanagan E, Wright EK, Gibson PR, et al
    Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in-utero.
    Clin Gastroenterol Hepatol. 2024 Mar 14:S1542-3565(24)00252.
    >> Share

  8. BAGER P, Hvas CL, Dahlerup JF
    Severe Fatigue in Inflammatory Bowel Disease: Dopaminergic Therapy with Modanfinil or Vitamin Therapy with Thiamine.
    Clin Gastroenterol Hepatol. 2024 Mar 18:S1542-3565(24)00283.
    >> Share


    Clin Res Hepatol Gastroenterol

  9. YANG J, Huang MMC, Liang MMJ, Lei MMY, et al
    The diagnostic performance of serum alphavbeta6 autoantibodies for ulcerative colitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2024;48:102317.
    >> Share


    Dig Dis Sci

  10. PEYRIN-BIROULET L, Bossuyt P, Bettenworth D, Loftus EV Jr, et al
    Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
    Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-023-08252.
    >> Share

  11. DEBOLT CA, Gottlieb ZS, Rao MG, Johnson S, et al
    Low-Dose Aspirin Use Does Not Increase Disease Activity in Pregnant Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 16. doi: 10.1007/s10620-024-08364.
    >> Share


    Gastroenterology

  12. KHROM M, Long M, Dube S, Robbins L, et al
    Comprehensive association analyses of extraintestinal manifestations in inflammatory bowel disease.
    Gastroenterology. 2024 Feb 27:S0016-5085(24)00232.
    >> Share


    Inflamm Bowel Dis

  13. JAIRATH V, Hunter Gibble T, Potts Bleakman A, Chatterton K, et al
    Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2024 Mar 21:izae044. doi: 10.1093.
    >> Share

  14. FIORINO G, Bent-Ennakhil N, Varriale P, Braegger F, et al
    Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment.
    Inflamm Bowel Dis. 2024 Mar 20:izae015. doi: 10.1093.
    >> Share

  15. JOLVING LR, Zegers FD, Lund K, Wod M, et al
    Children and Adolescents Diagnosed With Inflammatory Bowel Disease Are at Increased Risk of Developing Diseases With a Possible Autoimmune Pathogenesis.
    Inflamm Bowel Dis. 2024 Mar 20:izae047. doi: 10.1093.
    >> Share


    J Crohns Colitis


  16. Corrigendum to: Influence of Early Life Factors, including breast milk Composition, on the Microbiome of Infants Born to Mothers with and without Inflammatory Bowel Disease.
    J Crohns Colitis. 2024 Mar 20:jjae021. doi: 10.1093.
    >> Share

  17. VAN GENNEP S, Fung ICN, de Jong DC, Ramkisoen RK, et al
    Histological Outcomes And Jak-Stat Signalling In Ulcerative Colitis Patients Treated With Tofacitinib.
    J Crohns Colitis. 2024 Mar 20:jjae031. doi: 10.1093.
    >> Share

  18. CON D, Hilley P, Chin S, Corte C, et al
    Safety and effectiveness of Janus kinase inhibitors in the management of inflammatory bowel disease following liver transplantation.
    J Crohns Colitis. 2024 Mar 19:jjae039. doi: 10.1093.
    >> Share

  19. FUNG M, Farbod Y, Kankouni H, Singh S, et al
    Does combined medical and surgical treatment improve perianal fistula outcomes in patients with Crohn's disease? A systematic review and meta-analysis.
    J Crohns Colitis. 2024 Mar 16:jjae035. doi: 10.1093.
    >> Share


    J Gastroenterol

  20. HIRAYAMA D, Hyodo S, Morita K, Nakase H, et al
    Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis.
    J Gastroenterol. 2024 Mar 16. doi: 10.1007/s00535-024-02086.
    >> Share


    J Immunol

  21. CHENG MI, Hong L, Bustillos C, Chen B, et al
    Cutting Edge: Hypoxia Sensing by the Histone Demethylase UTX (KDM6A) Limits Colitogenic CD4+ T Cells in Mucosal Inflammation.
    J Immunol. 2024;212:1069-1074.
    >> Share


    PLoS One

  22. CHEN K, Zhang S, Cui G, Zhang X, et al
    Establishment of a hybrid model of atherosclerosis and acute colitis in ApoE-/- mice.
    PLoS One. 2024;19:e0289820.
    >> Share

  23. SALDOVA R, Thomsson KA, Wilkinson H, Chatterjee M, et al
    Characterization of intestinal O-glycome in reactive oxygen species deficiency.
    PLoS One. 2024;19:e0297292.
    >> Share


    Scand J Gastroenterol

  24. RADFORD SJ, Abdul-Aema B, Tench C, Leighton P, et al
    Substantial cost savings of ultrasound-based management over magnetic resonance imaging-based management in an inflammatory bowel disease service.
    Scand J Gastroenterol. 2024 Mar 19:1-7. doi: 10.1080/00365521.2024.2330588.
    >> Share

  25. KIASAT A, Prast-Nielsen S, Rautiainen S, Engstrand L, et al
    Plasma bile acids in association with Crohn's disease.
    Scand J Gastroenterol. 2024 Mar 20:1-9. doi: 10.1080/00365521.2024.2328592.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016